Back to Gene
NDP gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

NDP gene

The NDP gene provides instructions for making norrin, a protein essential for the development of the eye and the formation of blood vessels in the retina and inner ear.

Normal Function

The NDP gene provides instructions for making the protein norrin. This protein participates in chemical signaling pathways, including Wnt signaling, which regulates cell division, adhesion, and migration. Norrin binds to frizzled-4 receptors to initiate processes that regulate gene activity. This interaction is crucial for the specialization of retinal cells and the development of blood vessels in the eye and inner ear.

Health Conditions Related to Genetic Changes

Familial exudative vitreoretinopathy

Variants in the NDP gene can cause familial exudative vitreoretinopathy, a disorder that affects the retina and leads to progressive vision loss. These mutations disrupt norrin's ability to bind to frizzled-4, interfering with blood vessel formation at the edges of the retina and causing retinal damage.

Norrie disease

Norrie disease is an inherited disorder caused by NDP gene variants that prevent norrin from binding to frizzled-4. This leads to the accumulation of immature retinal cells and the failure of blood vessel formation in the eye, resulting in blindness in male infants. Because norrin is expressed in other body systems, the condition can also cause intellectual disabilities, seizures, and developmental delays.

Other retinal dystrophies

  • Coats disease: Causes leakage of retinal blood vessels and retinal detachment.
  • Persistent hyperplastic primary vitreous (PHPV): A condition where a remnant of a fetal blood vessel remains as a fibrous stalk, potentially causing cataracts, glaucoma, or retinal detachment.
  • Retinopathy of prematurity: Certain NDP variants have been associated with the worsening of this condition, which involves abnormal blood vessel growth in the retina.

Other Names for This Gene

  • ND
  • NDP_HUMAN
  • Norrie disease (pseudoglioma)
  • norrin

Frequently Asked Questions

Parents should watch for sudden flashes of light, floaters, or a sudden decrease in vision in one eye. A red or cloudy appearance of the retina seen during an eye exam, especially if the child has a family history of eye problems, can also be an early sign. Early referral to a pediatric ophthalmologist for a detailed retinal evaluation is recommended if any of these symptoms appear.
DNA sample, usually taken from a blood draw or a cheek swab, is sent to a specialized laboratory. The lab sequences the NDP gene and looks for known pathogenic variants. A positive result confirms a mutation that likely disrupts norrin’s ability to bind frizzled‑4, indicating a higher risk of retinal vascular abnormalities. It also informs family planning and allows early monitoring for vision changes.
Current treatments focus on managing complications: laser photocoagulation or cryotherapy can help seal leaking retinal vessels, and intravitreal injections may reduce edema. Vision‑restoring surgeries are rarely successful because the retinal structure is severely abnormal. Experimental gene therapy trials are underway, but they are still in early phases and not yet widely available. Patients should discuss participation with a research center specializing in retinal genetics.
Yes. Because norrin is expressed in the brain and inner ear, some patients with NDP mutations develop intellectual disability, seizures, or hearing loss. A comprehensive evaluation—including neurodevelopmental assessment, audiology testing, and brain imaging—can help detect and manage these extra‑ocular manifestations early. Regular follow‑ups with a neurologist and audiologist are advised for patients with confirmed NDP mutations.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA